Neuroelectronics and Biooptics: Closed-Loop Technologies in Neurological Disorders.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 25961887.
- Also identified by DOI 10.1001/jamaneurol.2015.0608 and PMC identifier 4501886.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Brain-implanted devices are no longer a futuristic idea. Traditionally, therapies for most neurological disorders are adjusted based on changes in clinical symptoms and diagnostic measures observed over time. These therapies are commonly pharmacological or surgical, requiring continuous or irreversible treatment regimens that cannot respond rapidly to fluctuations of symptoms or isolated episodes of dysfunction. In contrast, closed-loop systems provide intervention only when needed by detecting abnormal neurological signals and modulating them with instantaneous feedback. Closed-loop systems have been applied to several neurological conditions (most notably epilepsy and movement disorders), but widespread use is limited by conceptual and technical challenges. Herein, we discuss how advances in experimental closed-loop systems hold promise for improved clinical benefit in patients with neurological disorders.
Medical subject headings
- Deep Brain Stimulation
- Electrodes, Implanted
- Nervous System Diseases
- Optogenetics